XPeng's Monday Reckoning: A Record Recall, a Robot Gambit, and a Stock Caught Between Two Stories
Published on 08/22/2026 at 07:31 | Redaktion boerse-global.de
The numbers tell a story of erosion. XPeng's shares closed Friday at €10.44, a modest 1.4% gain that does little to mask the deeper damage: down 7.1% over the past month, down 42% year-to-date, and sitting 57% below the €24.40 November peak. For anyone who bought at the top, that is a painful hole. Yet Monday's second-quarter earnings release arrives with the company straddling two very different narratives—one of a Chinese EV sector in regulatory turmoil, the other of a manufacturer trying to rebrand itself as a robotics player.
The Recall That Isn't Really About XPeng
China's market regulator SAMR has triggered the largest automotive recall in the country's history, pulling more than seven million vehicles from eleven manufacturers over poorly visible emergency door-release mechanisms. XPeng's share of that total is roughly 264,800 vehicles across the G6, P7+, and X9 models—a fraction of Tesla's nearly three million, and proportionally smaller than the numbers posted by Xiaomi and Leapmotor.
The regulatory response is equally sweeping: from 2027, China will ban concealed door handles outright. That timeline matters because it frames the recall as an industry-wide reckoning rather than a company-specific failure. A separate, smaller recall in Malaysia—where importer Bermaz Xpeng is addressing front air-suspension issues on the X9, with the warranty extended to eight years—reinforces the point that this is a sector working through growing pains, not a single manufacturer's crisis.
Still, the timing is awkward. The same week saw at least eight Chinese automakers unveil new models in a single day, a pace one observer called "brutal." That competitive intensity, more than any recall, is what should concern long-term XPeng holders.
The Robot Pivot
Amid the noise, CEO He Xiaopeng has made a strategic move that has little to do with door handles or quarterly deliveries. He has personally taken charge of the robotics division, with mass production of humanoid robots slated to begin this year. The ambition is to reposition XPeng from a thin-margin automaker into a "Physical AI" player—the same category Tesla is chasing with its Optimus project.
Should investors sell immediately? Or is it worth buying XPeng?
Whether that bet pays off won't be decided on Monday, but it helps explain why some analysts remain constructive despite the share price carnage. The robotics narrative opens a new valuation dimension that pure auto sales cannot.
What the Numbers Are Expected to Show
The market's expectations for Q2 are cautiously optimistic. Analysts forecast revenue of $3.05 billion, a meaningful jump from the $2.53 billion reported in the year-ago quarter, with the per-share loss narrowing to $0.06 from $0.07. Delivery figures support the turnaround thesis: 103,295 vehicles in the second quarter, up 65% quarter-over-quarter.
The options market is pricing a post-earnings move of 9.42%, well above the historical average of 5.74%. History offers a cautionary note: XPeng has beaten earnings estimates in six of the past eight quarters, but has never delivered a positive revenue surprise—and recent post-earnings reactions have ranged from minus 10% to minus 8%.
A Split Verdict on the Street
The analyst community remains divided. Macquarie's target sits at $19, while Barclays cut its price target to $16 in March and now rates the stock "Underweight." The consensus target of $21.94 implies upside of more than 80%, and one GF-Value model suggests the shares are undervalued by roughly 58%. The price-to-sales ratio of 1.1 stands well below the historical average of 2.6.
But the bears have ammunition too. The Altman Z-score of 0.78 signals financial fragility, and a quantitative ranking system currently rates the stock a sell. Institutional activity in the last quarter was similarly mixed: 123 funds increased their positions while 138 reduced them.
The technical picture offers little clarity. The stock's recent 3.2% bounce over seven days looks like a corrective move rather than a reversal, and with volatility at 39% and an RSI of 44, the shares are neither oversold nor overbought—just stuck.
The Bottom Line
XPeng enters Monday's report with a valuation that looks cheap on several models, a recall that is more industry noise than company-specific damage, and a robotics story that could redefine the investment case. What it lacks is momentum and a clean bill of health from the analysts who matter. The Q2 numbers will show whether the operational improvement is real—or whether the skeptics at Barclays have it right. Either way, this remains a bet on Chinese growth with an open ending, not a settled proposition in either direction.
Ad
XPeng Stock: New Analysis - 22 August
Fresh XPeng information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
